Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantFRESENIUS KABI (SINGAPORE) PTE LTD
Licence HolderFRESENIUS KABI (SINGAPORE) PTE LTD
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, POWDER, FOR SOLUTION
INTRAVENOUS, INTRAMUSCULAR
Medical Information
H03AA01
levothyroxine sodium
Manufacturer Information
FRESENIUS KABI (SINGAPORE) PTE LTD
FRESENIUS KABI USA, LLC